Quality-of-life Assessment in Osteoporosis: Health-status and Preference-based Measures

Overview

Journal Pharmacoeconomics

Specialty Pharmacology

Date 2002 May 8

PMID 11994039

Citations 32

Authors

Anna N A Tosteson

Cristina S Hammond

Affiliations

Soon will be listed here.

Abstract

Health-status and preference-based approaches to assessing health-related quality of life (HR-QOL) in osteoporosis are reviewed. Osteoporosis-targeted health-status instruments [i.e. Osteoporosis Quality-of-Life Questionnaire (OQLQ), Osteoporosis Assessment Questionnaire (OPAQ), Quality-of-Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO), Osteoporosis-Targeted Quality-of-Life Questionnaire (OPTQoL), Osteoporosis Functional Disability Questionnaire (OFDQ), Quality-of-Life Questionnaire in Osteoporosis (QUALIOST)], which have been utilised to document the adverse impact of osteoporosis on HR-QOL in diverse clinical and epidemiological studies, are described first. Preference-based approaches to osteoporosis health-outcome measurement are then considered in both clinical and health policy settings. In the clinical setting, direct preference assessments [i.e. visual analogue scale (VAS), time tradeoff (TTO), standard gamble (SG)] using either experienced or described health outcomes have consistently shown significantly lower values for osteoporosis-related health states relative to usual or ideal health. In the health-policy context, preference-classification systems [i.e. EuroQoL (EQ-5D), Health Utilities Index (HUI)] for valuing health in economic studies are reviewed. At present, there is little evidence to guide the choice of one system over another for assessing the cost effectiveness of osteoporosis interventions; however, use of a consistent set of health-state values is essential. Further research is needed to characterise associations between osteoporosis-targeted health-status instruments and preference-based health-outcome measures. In addition, the longitudinal impact of osteoporosis and related fractures on HR-QOL must be documented.

Citing Articles

Choo Y, Mohd Tahir N, Said M, Makmor Bakry M Osteoporos Int. 2024; 35(5):745-757.

PMID: 38194151 DOI: 10.1007/s00198-023-07005-0.

Enhanced Risk Stratification for Short-Term Complications Following Vertebral Augmentation for Osteoporotic Vertebral Compression Fractures.

Shin J, Leggett A, Berg A, Harris C, Merchant A, Vives M Int J Spine Surg. 2023; 17(4):579-586.

PMID: 37460240 PMC: 10478692. DOI: 10.14444/8476.

Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.

Imai T, Tanaka S, Kawakami K, Miyazaki T, Hagino H, Shiraki M Osteoporos Int. 2017; 28(6):1893-1901.

PMID: 28265719 DOI: 10.1007/s00198-017-3966-7.

Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.

Sullivan S, Lehman A, Nathan N, Thomson C, Howard B Menopause. 2016; 24(4):371-378.

PMID: 27801706 PMC: 5365363. DOI: 10.1097/GME.0000000000000775.

Racial/Ethnic Differences in Bone Mineral Density of Young Adults.

Wilkin L, Jackson M, Sims T, Haddock B Int J Exerc Sci. 2016; 3(4):197-205.

PMID: 27182348 PMC: 4738873. DOI: 10.70252/NJIO5473.

References

Avioli L . Significance of osteoporosis: a growing international health care problem. Calcif Tissue Int. 1991; 49 Suppl:S5-7. DOI: 10.1007/BF02555078. View

Jette A . Functional Status Index: reliability of a chronic disease evaluation instrument. Arch Phys Med Rehabil. 1980; 61(9):395-401. View

Cantarelli F, Szejnfeld V, Oliveira L, Ciconelli R, Ferraz M . Quality of life in patients with osteoporosis fractures: cultural adaptation, reliability and validity of the Osteoporosis Assessment Questionnaire. Clin Exp Rheumatol. 1999; 17(5):547-51. View

Badia X, Prieto L, Roset M, Diez-Perez A, Herdman M . Development of a short osteoporosis quality of life questionnaire by equating items from two existing instruments. J Clin Epidemiol. 2002; 55(1):32-40. DOI: 10.1016/s0895-4356(01)00432-2. View

Randell A, Sambrook P, Nguyen T, Lapsley H, Jones G, Kelly P . Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int. 1995; 5(6):427-32. DOI: 10.1007/BF01626603. View

Merlino L, Bagchi I, Taylor T, Utrie P, Chrischilles E, Sumner 2nd W . Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients. Med Decis Making. 2001; 21(2):122-32. DOI: 10.1177/0272989X0102100205. View

Dequeker J, Ranstam J, Valsson J, Sigurgevisson B, Allander E . The Mediterranean Osteoporosis (MEDOS) Study questionnaire. Clin Rheumatol. 1991; 10(1):54-72. DOI: 10.1007/BF02208034. View

Brooks R . EuroQol: the current state of play. Health Policy. 1996; 37(1):53-72. DOI: 10.1016/0168-8510(96)00822-6. View

Torrance G, Furlong W, Feeny D, Boyle M . Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics. 1995; 7(6):503-20. DOI: 10.2165/00019053-199507060-00005. View

10.

Ettinger B, Black D, Mitlak B, Knickerbocker R, Nickelsen T, Genant H . Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282(7):637-45. DOI: 10.1001/jama.282.7.637. View

11.

Owens D . Spine update. Patient preferences and the development of practice guidelines. Spine (Phila Pa 1976). 1998; 23(9):1073-9. DOI: 10.1097/00007632-199805010-00023. View

12.

Salkeld G, Cameron I, Cumming R, Easter S, Seymour J, Kurrle S . Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000; 320(7231):341-6. PMC: 27279. DOI: 10.1136/bmj.320.7231.341. View

13.

Roland M, Morris R . A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976). 1983; 8(2):141-4. DOI: 10.1097/00007632-198303000-00004. View

14.

Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O . Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int. 1999; 10(2):150-60. DOI: 10.1007/s001980050210. View

15.

. Measuring quality of life in women with osteoporosis. Osteoporosis Quality of Life Study Group. Osteoporos Int. 1997; 7(5):478-87. View

16.

Ettinger B, Black D, Palermo L, Nevitt M, Melnikoff S, Cummings S . Kyphosis in older women and its relation to back pain, disability and osteopenia: the study of osteoporotic fractures. Osteoporos Int. 1994; 4(1):55-60. DOI: 10.1007/BF02352262. View

17.

Kaplan R, Atkins C, Timms R . Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis. 1984; 37(2):85-95. DOI: 10.1016/0021-9681(84)90050-x. View

18.

Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray T, Blondeau L . Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2001; 11(10):897-904. DOI: 10.1007/s001980070050. View

19.

Melton 3rd L . Hip fractures: a worldwide problem today and tomorrow. Bone. 1993; 14 Suppl 1:S1-8. DOI: 10.1016/8756-3282(93)90341-7. View

20.

Hollingworth W, Todd C, Parker M . The cost of treating hip fractures in the twenty-first century: short report. Osteoporos Int. 1996; 6 Suppl 2:13-5. DOI: 10.1007/BF01625236. View